Approach to involuntary movements: Clinical sciences

Last updated: January 30, 2025

Approach to involuntary movements: Clinical sciences

Topics for Physical Assessment

Topics for Physical Assessment

Approach to skin and soft tissue lesions: Clinical sciences
Approach to skin and soft tissue infections: Clinical sciences
Approach to skin and soft tissue injury: Clinical sciences
Approach to common skin rashes: Clinical sciences
Approach to a rash in the well newborn and infant: Clinical sciences
Approach to viral exanthems (pediatrics): Clinical sciences
Herpes zoster infection (shingles): Clinical sciences
Approach to anxiety disorders: Clinical sciences
Approach to sleep disorders: Clinical sciences
Approach to mood disorders: Clinical sciences
Approach to trauma and stressor-related disorders: Clinical sciences
Approach to a fever (0-60 days): Clinical sciences
Approach to a fever (over 2 months): Clinical sciences
Approach to a fever: Clinical sciences
Approach to growth faltering: Clinical sciences
Approach to back pain: Clinical sciences
Approach to joint pain and swelling: Clinical sciences
Approach to hip pain: Clinical sciences
Approach to foot pain: Clinical sciences
Approach to ankle pain: Clinical sciences
Approach to shoulder pain: Clinical sciences
Approach to knee pain: Clinical sciences
Approach to common musculoskeletal injuries (pediatrics): Clinical sciences
Juvenile idiopathic arthritis: Clinical sciences
Legg-Calve-Perthes disease and slipped capital femoral epiphysis: Clinical sciences
Developmental dysplasia of the hip: Clinical sciences
Approach to headache or facial pain: Clinical sciences
Concussion and traumatic brain injury
Approach to dizziness and vertigo: Clinical sciences
Approach to altered mental status: Clinical sciences
Approach to involuntary movements: Clinical sciences
Approach to tremor: Clinical sciences
Approach to polyneuropathy: Clinical sciences
Approach to acute vision loss: Clinical sciences
Approach to a red eye: Clinical sciences
Approach to facial palsy: Clinical sciences
Approach to amblyopia and strabismus (pediatrics): Clinical sciences
Eyelid disorders: Clinical sciences
Approach to head and neck masses (pediatrics): Clinical sciences
Approach to leukocoria (pediatrics): Clinical sciences
Approach to diplopia: Clinical sciences
Approach to peripheral lymphadenopathy (pediatrics): Clinical sciences
Approach to peripheral lymphadenopathy: Clinical sciences
Upper respiratory tract infection
Upper respiratory tract infections: Clinical sciences
Otitis media and externa (pediatrics): Clinical sciences
Allergic rhinitis: Clinical sciences
Influenza: Clinical sciences
Pharyngitis, peritonsillar abscess, and retropharyngeal abscess (pediatrics): Clinical sciences
Croup and epiglottitis: Clinical sciences
Acute group A streptococcal infections and sequelae (pediatrics): Clinical sciences
Infectious mononucleosis: Clinical sciences
Approach to a cough (acute): Clinical sciences
Approach to a cough (subacute and chronic): Clinical sciences
Atelectasis: Clinical sciences
COVID-19: Clinical sciences
Asthma: Clinical sciences
Bronchiolitis: Clinical sciences
Community-acquired pneumonia: Clinical sciences
Chronic obstructive pulmonary disease: Clinical sciences
Developmental milestones (newborn and infant): Clinical sciences
Well-child visit (newborn and infant): Clinical sciences
Well-child visit (toddler and child): Clinical sciences
Well-child visit (adolescent): Clinical sciences
Approach to a breast mass and asymmetry: Clinical sciences
Approach to breast pain (mastalgia): Clinical sciences
Approach to nipple discharge: Clinical sciences
Fibrocystic breast changes: Clinical sciences
Well-patient care (GYN): Clinical sciences
Cervical cancer screening: Clinical sciences
Approach to vulvar skin disorders: Clinical sciences
Approach to vaginal discharge: Clinical sciences
Sexually transmitted infection screening (GYN): Clinical sciences
Approach to primary amenorrhea: Clinical sciences
Approach to acute pelvic pain (GYN): Clinical sciences
Approach to dysmenorrhea: Clinical sciences
Approach to abnormal uterine bleeding in reproductive-aged patients: Clinical sciences
Approach to adnexal masses: Clinical sciences
Approach to hypertension: Clinical sciences
Approach to a murmur (pediatrics): Clinical sciences
Approach to congenital heart diseases (cyanotic): Clinical sciences
Approach to congenital heart diseases (acyanotic): Clinical sciences
Atrial fibrillation and atrial flutter: Clinical sciences
Congestive heart failure: Clinical sciences
Approach to dyspnea: Clinical sciences
Approach to chest pain: Clinical sciences
Aortic stenosis: Clinical sciences
Mitral stenosis: Clinical sciences
Hypertrophic cardiomyopathy: Clinical sciences
Approach to lower limb edema: Clinical sciences
Peripheral arterial disease and ulcers: Clinical sciences
Venous insufficiency and ulcers: Clinical sciences
Preconception care: Clinical sciences
Perinatal depression and anxiety: Clinical sciences
Antepartum care (third trimester): Clinical sciences
Antepartum care (second trimester): Clinical sciences
Antepartum care (first trimester): Clinical sciences
Venous thromboembolism in pregnancy: Clinical sciences
Approach to upper abdominal pain: Clinical sciences
Approach to periumbilical and lower abdominal pain: Clinical sciences
Approach to constipation: Clinical sciences
Approach to constipation (pediatrics): Clinical sciences
Approach to abdominal wall and groin masses: Clinical sciences
Approach to chronic abdominal pain (pediatrics): Clinical sciences
Approach to vomiting (pediatrics): Clinical sciences
Approach to diarrhea (pediatrics): Clinical sciences
Approach to melena and hematemesis (pediatrics): Clinical sciences
Well-patient care (geriatrics): Clinical sciences
Approach to unsteadiness, gait disturbance, or falls: Clinical sciences
Approach to dysarthria or dysphagia: Clinical sciences
Approach to gradual cognitive decline: Clinical sciences
Osteoporosis: Clinical sciences
Testicular cancer: Clinical sciences
Testicular torsion (pediatrics): Clinical sciences
Benign prostatic hypertrophy and prostate cancer: Clinical sciences
Approach to perianal problems: Clinical sciences
Inguinal hernias: Clinical sciences
Approach to dysuria: Clinical sciences
Approach to urinary incontinence (GYN): Clinical sciences
Approach to proteinuria (pediatrics): Clinical sciences
Urinary retention: Clinical sciences
Lower urinary tract infection: Clinical sciences
Approach to fatigue: Clinical sciences
Approach to unintentional weight loss: Clinical sciences
Approach to weakness (focal and generalized): Clinical sciences
Approach to a fever in the returned traveler: Clinical sciences

Decision-Making Tree

Transcript

Watch video only

Involuntary movements are unintentional body movements that can occur due to various conditions, including metabolic derangements, medication effects, and neurodegenerative conditions. There are several distinct types of involuntary movements, such as tremors, dystonia, myoclonus, and chorea, and the underlying pathology is different for each condition.

Important conditions associated with involuntary movements include those secondary to anti-dopaminergic medications, and neurologic conditions, such as Parkinson disease, Creutzfeldt-Jakob disease, Tourette syndrome, and Huntington disease.

Now, if a patient presents with involuntary movements, first obtain a focused history and physical examination, and order a complete metabolic panel. History reveals body movements that the patient cannot control. The physical exam shows abnormal movements that persist even if you distract the patient, while the complete metabolic panel is normal. These findings are suggestive of movement disorder.

Here’s a clinical pearl! Metabolic derangements can cause different abnormal movements. For example, hypocalcemia can increase membrane excitability of peripheral nerves and cause muscle fasciculations and tetany. Less commonly, hypomagnesemia and hypokalemia can also cause fasciculations and tetany. Lastly, renal or hepatic failure might lead to asterixis, which is flapping of the hands when the arms are outstretched.

Your next step is to assess the use of anti-dopaminergic medications, including antipsychotics, especially first-generation antipsychotics, and anti-emetics, such as metoclopramide. If your patient is taking an anti-dopaminergic medication, diagnose medication-induced movement disorder and determine the type of medication reaction the patient is having.

Let’s start with medication-induced dystonia. These patients report sustained muscle tightening, twisting of the body that typically involves the face and neck, and recent use of an anti-dopaminergic agent within the last few hours to days. On the physical exam, you’ll find sustained muscle contractions, such as torticollis; twisting of the tongue; trismus, which is contraction of the muscles of mastication resulting in lockjaw; or opisthotonus, which refers to an extreme arching of the neck and back. With these findings, diagnose medication-induced dystonia.

Okay, let’s discuss medication-induced Parkinsonism. In this case, patients report slowness, stiffness of movement, and possibly shaky hands at rest and frequent falls. Additionally, they have used an anti-dopaminergic agent in the last few weeks to months. On the physical exam, you’ll observe bradykinesia, rigidity, and, sometimes, rest tremor. In this case, diagnose medication-induced parkinsonism. Remember, patients with medication-induced parkinsonism are less likely to have a tremor than patients with idiopathic Parkinson disease, and the symptoms are more likely to be symmetric.

Finally, let’s look at tardive dyskinesia. Here, history reveals frequent grimacing, lip-smacking, eye blinking, or tongue protrusion and twisting. Patients might also report abnormal twisting or posturing of the limbs or body. This type of involuntary movement occurs when anti-dopaminergic medications have been used for months to years. Next, the physical exam reveals repetitive stereotyped movements of the perioral region, extremities, and/or trunk. In this situation, you can diagnose tardive dyskinesia.

Here’s a clinical pearl! Treatment for medication-induced movement disorders involves cessation of the offending agent and benzodiazepine. Keep in mind that unlike medication-induced dystonia and Parkinsonism, tardive dyskinesia may not resolve after stopping the medication.

Alright, let’s switch gears and discuss situations in which an anti-dopaminergic agent was not used. In this case, your next step is to assess if the main involuntary movement is a tremor. If it is, detailed history and physical exam will give you clues about the underlying cause, which most commonly includes Parkinson disease and essential tremor.

Patients with Parkinson disease report shaky hands at rest, slowness of movement, sometimes in combination with frequent falls, and a loss of smell. The physical exam reveals bradykinesia, which is slowness of movement and a decrease in amplitude or speed with continued movement. Additionally, you’ll notice a pill-rolling tremor at rest and rigidity.

Moreover, if you passively move the patient’s limb, you might feel a series of stops or stalls, which is known as cogwheeling or cog-wheel rigidity. Some patients could also present with facial masking, which refers to an impaired facial expression in response to emotion, shorter stride length, and a stooped posture. At this point, consider Parkinson disease, and start a trial of dopaminergic therapy with levodopa and carbidopa.

Next, assess the supportive criteria for Parkinson disease, which include adequate response to dopaminergic therapy, levodopa-induced dyskinesia, the presence of a rest tremor of a limb, and olfactory loss or cardiac sympathetic denervation. If you find at least two of the four supportive criteria, diagnose Parkinson disease.

Sources

  1. "Movement Disorder Society task force viewpoint: Huntington's disease diagnostic categories" Mov Disord Clin Pract (2019)
  2. "Chapter 21: Tourette’s and tic disorders" Handbook of DSM-5 Disorders in Children and Adolescents, 1st ed. (2017)
  3. "MDS clinical diagnostic criteria for Parkinson's disease" Mov Disord (2015)
  4. "Chapter 359: Acute rheumatic fever" Harrison's Principles of Internal Medicine, 21st ed. (2022)
  5. "Rapidly progressive dementia" Continuum (Minneap Minn) (2022)
  6. "Medication-induced movement disorders" Cambridge University Press (2015)
  7. "Chorea" Continuum (Minneap Minn) (2022)
  8. "Validation of revised international Creutzfeldt-Jakob disease surveillance network diagnostic criteria for sporadic Creutzfeldt-Jakob disease" JAMA Netw Open (2022)